Dyadic International, Inc.
NASDAQ:DYAI
Overview | Financials
Company Name | Dyadic International, Inc. |
Symbol | DYAI |
Currency | USD |
Price | 1.94 |
Market Cap | 57,403,436 |
Dividend Yield | 0% |
52-week-range | 0.93 - 2.67 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Mark A. Emalfarb |
Website | https://www.dyadic.com |
An error occurred while fetching data.
About Dyadic International, Inc.
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD